SAMA Schultze Special Purpose Acquisition

Clever Leaves Cannabis Operations Declared Carbon Neutral; a First for a Vertically Integrated Medicinal Cannabis Company

Clever Leaves Cannabis Operations Declared Carbon Neutral; a First for a Vertically Integrated Medicinal Cannabis Company

The CO2 Neutrality Certification Reflects Clever Leaves’ Commitment to Environmental Sustainability and long-term vision for the cannabis industry.

Sustainable cannabis production has a significant impact on the environment: Clever Leaves generates just 16 kilograms of CO2 compared to traditional "indoor" cultivation methods that generate up to 2,300 to 5,200 kilograms of CO2 per kilogram of dried flower.

TOCANCIPÁ, Colombia, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), a global medicinal cannabis company, announced today that it has been awarded the International Declaration of Carbon Neutrality by 100% Carbon Neutral Program for its active commitment to environmental sustainability and climate change mitigation. Clever Leaves is the first known vertically integrated medicinal cannabis company worldwide to have achieved international certification for carbon-neutrality.

Clever Leaves is taking proactive steps to address the challenges posed by climate change through implementing a range of efficiency measures to curb carbon emissions and preserve natural resources. These measures include using passive techniques to harness solar energy and optimizing waste management practices. The Company has also forged partnerships with local recycling associations, initiated reforestation projects, and integrated rainwater into its irrigation processes. Through sustainable practices, the company repurposes or recycles more than 50% of waste into productive processes.

“At our core, we work for being a sustainable company. We are among the first large vertically integrated medicinal cannabis companies operating in the newly legal industry, and it is incumbent on us to build an industry that is sustainable and environmentally sound from the start. We feel that there is no better time than now to double-down on our commitment to sustainability and are dedicated to mitigating climate change wherever possible. We are proud to know that our flower and extracts being sold globally are grown and manufactured in a carbon-neutral environment. Furthermore, we believe this will also prove to be important to our clients, physicians, and patients.” said Andres Fajardo, CEO of Clever Leaves.

While producing a kilogram of dried flower, Clever Leaves generates just 16 kilograms of CO2, compared to traditional "indoor" cultivation methods that generate up to 2,300 to 5,200 kilograms of CO2 per kilogram of dried flower. The Company’s energy consumption per kilogram of dried flower is 62 kilowatt-hours, in stark contrast to "indoor" usage of up to 5,000 kilowatt-hours1

Through the implementation of sustainable practices, Clever Leaves' carbon footprint stood at 318 tons of carbon dioxide equivalent (CO2e) across all production operations in 2022. Furthermore, Clever Leaves has offset its remaining emissions by acquiring international carbon credits from carbonfund.org and supporting emission reduction projects.

This entire process adheres to the GHG Protocol standard and has undergone thorough evaluation and verification by "La Tercera Mirada" and the "International 100% Carbon Neutral Program.”

“The fight against climate change requires the commitment of everyone, but mainly from companies that are leaders in their industries. That is why working together with Clever Leaves and turning them into the first Latin American company with the 100% Carbon Neutral® Company certification, has been a truly gratifying experience and one that solidifies the Latin American fight against climate change.” said Javier Segura, COO for LATAM of the 100% Carbon Neutral Program®.

About Clever Leaves Holdings Inc.

Clever Leaves is a global medicinal cannabis company. Its operations in Colombia produce cannabinoid active pharmaceutical ingredients (API) and finished products ​in flower and extract form to a growing base of B2B customers around the globe. Clever Leaves aims to disrupt the traditional cannabis production industry by leveraging environmentally sustainable, ESG-friendly, industrial-scale, and low-cost production methods with the world’s most stringent pharmaceutical quality certifications. For more information, please visit 

Press Contacts:

Maria Petsanas / Anne Donohoe

KCSA Strategic Communications



Commercial Contact:

Andrew Miller

Head of Global Business Development



______________________

1 Transnational Institute. “Cannabis and climate: The carbon footprint and energy use of indoor cultivation. 20 October 2022.



EN
29/08/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Schultze Special Purpose Acquisition

 PRESS RELEASE

Clever Leaves Announces Voluntary Delisting and SEC Deregistration

Clever Leaves Announces Voluntary Delisting and SEC Deregistration TOCANCIPÁ, Colombia, April 26, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, today announced that its Board of Directors (the “Board”) determined to voluntarily delist its common shares, without par value (the “common shares”) and warrants, each exercisable for 1/30th common share at an exercise price of $11.50 (the “Warrants” and together with the common shares, the “Securities”) from The Nasdaq Stock Market LLC (“Nasdaq”...

 PRESS RELEASE

Clever Leaves Reports Fourth Quarter and Full Year 2023 Results

Clever Leaves Reports Fourth Quarter and Full Year 2023 Results - 2023 Revenue Increased 6% Year-Over-Year, with a 39% Increase in Full-Year Cannabinoid Revenue - - Drove Year-over-Year General and Administrative Expense Reductions of 26% in Q4 2023 and 24% for the Full Year - - Completed Sale of Non-Cannabinoid Herbal Brands Business on March 21, 2024 for $8.02 Million, Including $7.02 Million in Cash Paid at Closing - TOCANCIPÁ, Colombia, April 01, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabi...

 PRESS RELEASE

Clever Leaves and Paradise Seeds to Develop and Register Genetic Asset...

Clever Leaves and Paradise Seeds to Develop and Register Genetic Assets in Colombia TOCANCIPÁ, Colombia, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, announced today that through its partnership with award-winning Dutch seed bank, Paradise Seeds (“Paradise”), to develop and register high performance cannabis cultivars in Colombia, Clever Leaves will have exclusive license to cultivate some of these genetics, while Paradise will make other cultivars available to third parties for...

 PRESS RELEASE

Clever Leaves Granted Australian GMP Certification for Cannabis Produc...

Clever Leaves Granted Australian GMP Certification for Cannabis Products by the Therapeutic Goods Administration (TGA) Multinational operator has been granted Australian GMP certification by the TGA for the manufacturing of cannabis products. Clever Leaves is the first and only medicinal cannabis company globally that has GMP certifications from the European Union, Colombia, Brazil and Australia. TOCANCIPÁ, Colombia, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), a global medicinal cannabis company, announced today that it has been granted Australia...

 PRESS RELEASE

Clever Leaves Reports Third Quarter 2023 Results

Clever Leaves Reports Third Quarter 2023 Results - Q3 Revenue Increased 33% Year-Over-Year, Propelled by 135% Year-Over-Year Growth in Cannabinoid Revenue, Along with 6% Year-Over-Year Growth in Non-Cannabinoid Revenue - - Q3 Adjusted EBITDA Improved Year-Over-Year to $(2.6) Million Compared to $(3.7) Million, Reflecting Revenue Growth and Continued Aggressive Expense Reductions - - Cash Balance at October 31, 2023 was $6.2 Million, with $1.9 Million in Subsequent Capital Received from the November Sale of the Company’s Remaining Stake in Cansativa - - Updated Full Ye...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch